**Sangkyu Lee**

Ph.D. (Associate Professor) acquired his B.S. degree in Pharmacy in 2002 from Yeungnam University in Gyeongsan, Korea, and a Ph.D. in Toxicology in 2007 from the same university. He then joined Doping Control Center, Korea Institute for Science and Technology (KIST), Seoul, in 2007–2009 and Ben May Department for Cancer Research, The University of Chicago, Chicago, USA, in 2009–2011, where he was a postdoctoral fellow. At KIST, he studied drug metabolism and drug interactions with his supervisor, Prof. Dong Hyun Kim. In 2011, he joined College of Pharmacy, Kyungpook National University in Daegu, Korea, and currently serves as an Associate Professor. As a toxicologist, his research has focused on using mass spectrometry, and he is conducts research on drug metabolism, drug interactions, and the pharmacokinetics of new drug candidates or naturally active substances. He is also an expert in mass spectrometry-based toxicometabolomics and toxicoproteomics research. He has published close to 190 peer-reviewed articles. Dr. Lee's research is supported by the National Research Foundation (NRF) of Korea gran<sup>t</sup> founded by the Korea government. He is currently Vice Director of BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, having started in this position in 2020, and he also serves on the Editorial Board of *Mass Spectrometry Letters* (Scopus).
